Jana Care founders Sidhant Jena, Michal Depa, and Prof. Tarun Khanna were challenged by an enterprising physician-entrepreneur (Dr. Devi Shetty) to build a smartphone app for health workers to screen for Oral Cancer and Cardiovascular Disease in remote rural communities in India in 2009 (just six months after Android was launched). What began as a side project during graduate school has grown into one of the world’s largest chronic disease screening programs, resulting in Jana Care.
What do they do?
They make high-quality diagnostics for mobile labs. They create and produce cutting-edge in-vitro diagnostic medical gadgets. They are dedicated to providing their consumers with the best possible items.
Their ISO 13485:2016-certified Quality Management System allows them to maintain tight controls at every stage of product development, manufacture, and distribution. They promote a culture of continual development within their company and collaborate closely with their suppliers to achieve excellence.
Salient Features of their Services
Their patented technology provides laboratory equipment that meets or exceeds industry standards at a reasonable price.
Simple to Use
Through simple tests that are quick and eliminate misunderstanding, their design maintains point-of-care procedures efficiently.
Individual providers, decentralized healthcare systems, and large-scale networked enterprises can all benefit from their mobile platform, which is secure and plug-and-play ready.
They provide Immunoassay, enzymatic, and chemical affinity assays that may all be read with their universal optical reader. The optics are tiny, inexpensive, and allow several tests to be evaluated on the same reader thanks to their innovative design.
They may use over-the-air software upgrades to reprogram ‘Aina’ devices in the field for new testing, and they can also identify devices that need to be repaired and troubleshoot them remotely to ensure quality and dependability at scale.
To make diagnostic tests, they construct layers of porous materials, such as paper, that are covered with dry chemicals. Capillary action causes passive flow across or through a strip when it comes into touch with blood, the flowing liquid activates the chemistry, and the chemical provides a signal that the ‘Aina’ device can read.
Their Aina gadget, an optical reader capable of reading many modalities, reads the signals on the test strip (colorimetric and fluorescent). The optics are tiny, inexpensive, and allow several tests to be evaluated on the same reader thanks to their innovative design. Aina’s versatility permits it to be utilized for experiments we haven’t thought of yet.
Their Mobile Connected Platform
There are numerous benefits to having a mobile-friendly platform. They can use over-the-air software upgrades to reprogram Aina devices in the field for new tests, as well as identify devices that need to be maintained and troubleshoot them remotely, ensuring quality and dependability at scale.
How is their technology different from its competitors?
In primary and community care settings, there is an unmet demand for an affordable diagnostic system for chronic illness management. Diagnostic tests based on array technologies and microfluidics necessitate costly equipment and capital-intensive production. These diagnostics may be appropriate for established hospitals that need to examine hundreds of samples at a time, but they are not designed to meet the needs of the community and home care. JanaCare solves this problem through its cost-effective technology.
|Company size||51-200 employees|